Beyond genomics: Multidimensional analysis of cancer therapy resistance Journal Article


Authors: Philip, M.; Schietinger, A.
Article Title: Beyond genomics: Multidimensional analysis of cancer therapy resistance
Abstract: Cancer resistance to therapy occurs through a selection process generally thought to be driven by mutations. In a recent study, Hugo et al. use multidimensional analysis of the dynamic genetic, transcriptional, epigenetic, and immune landscape alterations in baseline and MAPK inhibitor-resistant melanoma tumors, demonstrating a role for 'non-genomic' drivers in cancer evolution. © 2015.
Keywords: gene mutation; nonhuman; genetic analysis; cd8+ t lymphocyte; cancer immunotherapy; melanoma; gene expression; mitogen activated protein kinase inhibitor; epidermal growth factor receptor; protein tyrosine kinase; cancer therapy; dna methylation; cancer resistance; antigen presentation; immune response; transcription regulation; epigenetics; genomics; short survey; down regulation; upregulation; lymphocytic infiltration; cytotoxic t lymphocyte antigen 4; macrophage; fibroblast growth factor receptor 2; lymphoid enhancer factor 1; cd163 antigen; programmed death 1 receptor; tumor microenvironment; b raf kinase inhibitor; monocyte chemotactic protein 2; human; oncogene c fos; wnt11 protein
Journal Title: Trends in Immunology
Volume: 36
Issue: 11
ISSN: 1471-4906
Publisher: Elsevier Inc.  
Date Published: 2015-11-01
Start Page: 665
End Page: 667
Language: English
DOI: 10.1016/j.it.2015.09.003
PROVIDER: scopus
PUBMED: 26440701
PMCID: PMC5104493
DOI/URL:
Notes: Export Date: 2 December 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mary   Philip
    7 Philip